nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bevacizumab-associated bowel perforation after stent placement for metastatic rectal adenocarcinoma in a patient with ulcerative colitis
|
Braik, Tareq |
|
2010 |
7 |
12 |
p. 562-564 3 p. |
artikel |
2 |
Cabazitaxel and prednisone as second-line therapy of metastatic, castration-resistant prostate cancer
|
Abraham, Jame |
|
2010 |
7 |
12 |
p. 540-542 3 p. |
artikel |
3 |
Cabazitaxel improves survival in castration-resistant prostate cancer patients with disease progression on docetaxel
|
Jana, Bagi R.P. |
|
2010 |
7 |
12 |
p. 542-543 2 p. |
artikel |
4 |
Causation
|
Streiner, David L. |
|
2010 |
7 |
12 |
p. 573-575 3 p. |
artikel |
5 |
Implications of postmastectomy radiation therapy on optimal timing and approach for breast reconstruction
|
Shen, Jeannie |
|
2010 |
7 |
12 |
p. 548-560 13 p. |
artikel |
6 |
Oncology patient-centered medical home and accountable cancer care
|
Sprandio, John D. |
|
2010 |
7 |
12 |
p. 565-572 8 p. |
artikel |
7 |
One practice's battle in the access/delivery war
|
Young, Patrick |
|
2010 |
7 |
12 |
p. 576- 1 p. |
artikel |
8 |
Perspectives on the value and science in integrated cancer care
|
Bosserman, Linda D. |
|
2010 |
7 |
12 |
p. 532- 1 p. |
artikel |
9 |
The goal of finding a standard therapy for refractory HER2-positive metastatic breast cancer remains out of reach
|
Cianfrocca, Mary |
|
2010 |
7 |
12 |
p. 546- 1 p. |
artikel |
10 |
Trastuzumab-DM1 in extensively pretreated patients with HER2-positive metastatic breast cancer
|
Abraham, Jame |
|
2010 |
7 |
12 |
p. 544-545 2 p. |
artikel |